Meet the team

Paul Craddy founded Remap Consulting in January 2014 to help clients optimise their pricing, health economics and market access outcomes.

Prior to that, Paul was Head of Diabetes for Pricing, Market Access and Health Economics for EUCAN within Takeda Pharmaceuticals. In this role, Paul was responsible for leading the franchise including managing the launch of a new diabetes therapy, providing input into R&D for pipeline products and optimising in-market products. Paul was also a member of the PMAHE management team, helping set the strategic direction of the PMAHE department.

During his time in Nycomed, Paul led the strategic pricing team responsible for global pricing decisions for Nycomed’s global brands. He was also a core member of the PMAHE integration team during the Takeda takeover, helping to design and implement the new PMAHE organisation within Takeda.

Preceding Nycomed, Paul was a PMA consultant with IMS Consulting based in Cambridge, UK. Here, he managed numerous global PMA projects across a variety of international clients, developing launch pricing strategies, creating payer value propositions & communications and managing market access reorganisations.

Paul holds a PhD in molecular biology from Edinburgh University and has a BSc Biology from Manchester University.

With over 20 years pharmaceutical experience, within both consultancy and pharmaceutical companies, Graham brings expertise in embedding market access drivers into clinical development programme; developing global product launch pricing strategies and producing HTA submissions to address payers’ pricing and reimbursement requirements.

Graham’s industry experience includes GSK, start-up biotech companies and Ferring pharmaceuticals. During his time at Ferring Graham was Global Head of Market Access and Pricing taking responsibility for all market access activities from incorporation of payer value into clinical development programs through to development and implementation of the market access and pricing strategy for global product launches.

Graham’s consultancy experience was obtained within both IMS consulting (previously Cambridge Pharma) and Adelphi Values whereby he was responsible for global pricing and reimbursement projects ranging from strategic insights to global pharmaceutical companies; market access training to senior management and affiliates; development of biosimilar access strategies and EU pricing and reimbursement submissions.

Graham has worked across many therapeutic areas including Oncology, Gastroenterology, Urology, Fertility, Obstetrics and Endocrinology.

Graham has a Ph.D. in neuropharmacology from Durham University and an MBA from Aston University. He currently lives in near Manchester, UK.

Charlie has 10 years of experience in the pharmaceutical industry, split between both consultancy and NICE. Prior to joining Remap Consulting, Charlie worked at a pharmaceutical market research agency and a healthcare strategy consulting company, acting as the main client lead on life science consultancy projects for companies ranging from small biotech to large global pharma. Charlie also spent over 2 years working in NICE’s technology appraisals team, where he led the development of committee materials and guidance documents across a wide range of therapy areas.

Charlie is experienced in managing pricing and market (PMA) access projects for pharmaceutical and biotech clients, including pricing and reimbursement landscape analyses, health technology assessment (HTA) dossier development, HTA scientific advice (both parallel and individual), payer advisory boards and interviews, value proposition and value dossier development, pricing strategies and training materials. Charlie has PMA expertise across a range of therapy areas and topics, including psoriasis, ulcerative colitis and Crohn’s disease, biosimilars, multiple myeloma and DLBCL.

Charlie has an MSc in Biomaterials and Tissue Engineering from University College London, and a BSc in Biological Sciences from the University of Warwick.

With over 18 years of experience in the field of people and talent acquisition, Christina is a seasoned professional who has gained a deep understanding of the challenges associated with acquiring and retaining top talent in the Market Access and HEOR sp ace. For the past seven years, she has been an instrumental part of the transformation and growth of PRMA Consulting worldwide, now known as Avalere Health, serving as their Global People Director.

Christina possesses a passionate and can-do attitude. Her work is firmly anchored in a values-driven and positive mindset, always striving to find pragmatic solutions to even the most challenging situations. She leads by example, inspiring her colleagues to excel in their roles.

An essential aspect of Christina’s leadership is her high emotional intelligence and sensitivity, enabling her to adapt her management style to suit the unique needs of each individual. This approach fosters strong buy-in from team members and creates a supportive and collaborative work environment.

Christina is a dedicated advocate for employee well-being and diversity, equity, and inclusion initiatives throughout the employee lifecycle. She serves as a mental health first aider, demonstrating her commitment to supporting the health of her colleagues and creating an inclusive workplace where every individual feels valued and heard.

Fatima has extensive experience in the pharmaceutical industry, both within consultancy and NICE.

Prior to joining Remap, Fatima worked at Consulting for McCann Health, where she supported clients in the development of value propositions and global value dossiers. Fatima also spent nearly 3 years working in NICE’s technology appraisals team, where she provided technical leadership during the appraisal process, including through development of committee materials and guidance documents.

During her time at Remap, Fatima has gained significant experience in managing projects and supporting clients through their market access journey. This has included pricing and reimbursement landscape analyses, opportunity assessments, market access strategy development, HTA dossier development and the development and delivery of training materials. Fatima has PMA experience across a range of therapeutic areas, including in oncology, rare diseases and autoimmune diseases.

Fatima has a BSc in Biomedical Sciences from the University of Manchester.

With over a decade in academic research prior to transitioning into HEOR and market access consultancy, Ashley brings a combination of scientific depth, strategic insight, and creative problem-solving to her role as Director.

Ashley’s consultancy experience spans the asset lifecycle, from early pipeline and landscape assessment to global launch preparation and local adaptation. She has led projects encompassing asset planning, primary research, and evidence synthesis, and has a specialisation in developing compelling value-based narratives and value communication materials to support market access success. Ashley prides herself on fostering a collaborative environment and developing strong partnerships that ensure the delivery of high-quality strategically aligned outputs.

Her prior experience includes a fellowship with Mount Sinai Innovation Partners in New York City, where she gained expertise in early asset commercialisation. Prior to joining Remap, she worked at Adelphi Values PROVE, where she provided senior leadership on projects across diverse therapeutic areas, with additional responsibilities in business development and continuous improvement.

Ashley holds a first-class BSc (Hons) in Biochemistry from the University of Manchester and a PhD in Molecular and Cellular Biology from University College London, which was sponsored by Cancer Research UK.

Mike is an associate director who is proficient in working with clients to understand and provide solutions to their market access problems.

Over the last five years at Remap Consulting, he has gained significant experience in managing projects, from rapid-fire commercial assessments, payer research programs, structural re-organisation and HTA submissions. Additionally, Mike has developed expertise in the development and delivery of training of complex market access and pricing topics.

Mike has been involved on projects covering a diverse range of healthcare topics, particularly in dermatology, rare diseases and endocrinology.

Prior to joining Remap Consulting, Mike was a Medical Affairs Operations Executive at ViiV Healthcare, working in projects involving digital clinical data tools, medical affairs governance and process improvement initiatives.

Mike has a BSc in Pharmacology from the University of Leeds.

Tom is passionate about working at the forefront of pharmaceutical market access while being guided by strong values of honesty and integrity. He is dedicated to achieving the swiftest possible patient access to vital medicines while making sure the needs of all stakeholders are balanced. Tom has a genuine commitment to building collaborative relationships and focuses on delivering practical ethical solutions that not only meet client goals but also help drive healthcare innovation and improve patient outcomes across the UK, Europe and beyond.

With almost a decade of experience Tom has held key roles in both consultancy and at NICE where he led market access and health economics projects coordinated multidisciplinary teams and played an active role in successful payer negotiations that sped up access to for patients. Tom combines strategic thinking with resourceful leadership to deliver strong and effective solutions for clients.

Tom’s core strengths include strategic market access, health economics, managing HTA processes, policy analysis and project management. His academic background in Health Technology Assessment Pricing and Reimbursement from the University of Sheffield supports his professional work.

Outside of work Tom’s personality shines through in his creativity and love for adventure. He trains in Muay Thai at the Sitsiam Camp/Buddhai Swan in Manchester, enjoys cooking a wide variety of dishes Nigerian food being a particular favourite, baking of all sorts, hiking, drone photography, home renovations, and exploring new places through European and global travel.

Tom is also a mentor with Bridging Barriers to those in early careers showing dedication to personal development and helping the next generation of professionals in life sciences. He balances his professional commitments with personal passions that showcase his continuous curiosity open-mindedness and strong sense of community.

For Tom combining integrity expertise and genuine connection is what drives his approach bringing trust impactful results and collaboration to every project and partnership.

Higia Vassoler is recognised for her expertise in pricing, reimbursement, and market access strategy across global pharmaceutical markets. With over a decade of experience, she has delivered evidence-based solutions that inform critical decisions on product launches, value communication, and pricing and access optimisation.

Higia has led high-impact engagements across oncology, neurology, immunology, and rare diseases, guiding senior leadership teams through complex strategic and policy challenges. Holding an MSc in Drug Discovery and Development (Distinction, UCL) and a Postgraduate Certificate in Health Economics (University of York), she combines scientific rigour with strategic acumen.

Fluent in English and Brazilian Portuguese, with advanced proficiency in French, she thrives in multicultural and cross-functional environments. Beyond market access, she is passionate about fostering diversity and inclusion in the workplace; and through thought leadership, Higia enjoys contributing to the dialogue on equitable access to healthcare innovation.

Kavitha is an experienced consultant with a rich background in diverse therapeutic areas, collaborating with pharmaceutical companies on multifaceted projects.

Over the past seven years, Kavitha has honed her expertise in real-world evidence consulting, crafting value dossiers, and developing compelling payer value propositions. Her skills extend to conducting systematic and targeted literature reviews, formulating HTA strategies and orchestrating market access launch plans.

Kavitha’s academic journey led to her to earn a DPhil in Biochemistry from the prestigious University of Oxford in 2021, laying the foundation for her impactful career in the pharmaceutical consulting landscape.

With a passion for bridging science and business, Kavitha consistently brings a wealth of knowledge and strategic acumen to her consultancy endeavours.

Lauren is a consultant with ample academic experience and is dedicated to providing a high working standard to understand clients’ market access problems and to facilitate their needs.

Since joining Remap Consulting she has gained experience in pricing research, economic model development, competitive landscape analysis, payer research, analogue analysis and HTA submissions. Projects have covered a range of therapy areas but those with a special focus have included diseases of the CNS, fertility-related diseases, and rare diseases.

Prior to joining Remap Consulting Lauren gained a grounding in market access at DRG Abacus and gained experience in creating, co-ordinating and delivering training materials through a teaching role at Imperial College London.

Lauren obtained a first-class degree in Biology at the University of York and went on to gain a masters and Ph.D. from The National Heart and Lung Institute at Imperial College London where she focused on the molecular responses after cardiac injury.

Gillian is a consultant with over four years’ experience in market access who is dedicated to delivering high quality work and tailored solutions that meet clients’ needs.

Prior to joining Remap Consulting, Gillian worked at a pharmaceutical consultancy where she gained a breadth of experience in managing the delivery of value dossiers, health technology assessment (HTA) compliant literature reviews, health state utility studies, and payer value communication tools. As the primary client contact and project lead, Gillian ensured the development of high-quality deliverables to inform clients’ decision-making and optimise market access success. Across projects, Gillian has developed expertise in a number of therapy areas including infectious diseases, chronic inflammatory conditions, rare diseases, and oncology.

Gillian has a BSc in Biomedical Science from the University of Sheffield where she specialised in pharmacology and physiology.

Grace is a consultant with extensive expertise in market access, project management, and strategic communication within the Life Sciences sector. She has worked closely with pharmaceutical clients to develop data-driven solutions and navigate complex market access challenges.

Most recently, Grace was a Market Access Specialist at LCP Health Analytics, where she provided strategic insights to support pharmaceutical product launches and reimbursement strategies. She has also contributed to influential research in oncology and pharmaceutical pricing, authoring industry-recognized articles that inform healthcare decision-making.

Grace’s experience includes collaborating with key stakeholders to drive evidence-based strategies and optimize market access pathways. Her strong analytical skills and strategic approach enable her to deliver impactful solutions in an evolving healthcare landscape.

Grace holds an MRes in Cancer Sciences from the University of Birmingham, as well as a BSc (Hons) in Biomedical Science from the University of Reading.

Sam is a senior analyst whose prior experience in client-orientated roles, allows him to efficiently understand clients’ needs and provide effective assistance.

Prior to joining Remap Sam completed a BSc in Biochemistry at the University of Bath before going on to obtain a distinction for his master’s degree in Biotechnology and Enterprise at the University of Manchester. Both these academic successes have helped Sam develop his primary and secondary research skills on projects in areas such as scaffold design for regenerative medicine and cancer epigenetics. From this, Sam gained valuable expertise in data analysis and is passionate about applying these skills and experiences to meet the needs of his clients.

During his time at university, Sam participated in extracurricular activities allowing him to gain experience in collaborating, coordinating, and communicating on projects to deliver a valuable outcome.

Vishal is a senior analyst with prior experience in client-facing roles, enabling him to effectively assess and accommodate clients’ needs.

During Vishal’s time at university, he contributed to research into cerebral small vessel disease, developing a variety of skills in both primary and secondary research. This experience also helped Vishal to gain the knowledge to perform systematic literature reviews, generate reports and presentations, and to work as part of a research team. Furthermore, Vishal gained valuable experience into data analysis and is summarily passionate about using these skills to the benefit of his clients.

Vishal studied at the University of Manchester where he obtained a first-class MSci degree in Neuroscience.

Abigayle is a seasoned market access analyst having contributed to a diverse range of projects including primary research, target access profiles, and value communications. She excels in e-learning content creation, enhancing scientific communication for a broad audience through both traditional and innovative formats. With a particular interest in oncology, she is passionate about staying informed on cutting-edge treatments in the field.

Abigayle holds a BSc in Biochemistry and a MSc in Biotechnology and Enterprise from the University of Manchester, where she graduated with Distinction in 2022. Outside of her professional pursuits, she enjoys spending quality time with friends and family and travelling.

Leslie has substantial clinical and academic experience, is committed to the highest standards and is capable of facilitating the provision of bespoke solutions to clients’ pricing and market access needs. 

Leslie is a medical doctor with over nine years of clinical experience. Upon completion of her medical degree at the National Autonomous University of Mexico, she specialised in Otolaryngology-Head and Neck Surgery. During her years of clinical practice in Mexico, she gained experience working in secondary and tertiary care across the different national healthcare subsystems.

Prior to joining Remap, she completed a masters degree in Translational Medicine and a Ph.D. in Genomics from the University of Manchester. Whilst based in the multidisciplinary environment of the North West Genomic Laboratory Hub (NHS), Leslie developed several research skills and expanded her knowledge on a breadth of genetic rare disease disorders and the role of genomic strategies in precision medicine.

Julia is an analyst whose extensive experience in client-oriented roles allow her to efficiently assess clients’ needs and provide professional assistance.

During her time at university, Julia gained valuable insight into all stages of drug design and development. She sharpened her primary and secondary research skills on projects from areas including biocatalysis for drug development and metabolomics in disease diagnostics. As an avid educator with an analytical mind, Julia is passionate about finding the most effective ways of communicating complex data and ideas.

Julia studied Chemistry with Medicinal Chemistry at the University of Manchester and is awaiting to graduate with First Class Bachelor’s degree this September.

Giulia is a senior analyst with extensive experience across multiple client-facing sectors, enabling her to understand how to best address different clients’ needs.

Prior to joining Remap, Giulia achieved a Master’s Degree in Philosophy, Politics and Economics of Health at UCL, where she focused on HTA processes and the cross-country variation in the value assessments of drugs and medical devices. She is also trained in critical appraisals of both primary and secondary research, including systematic reviews and hence has a comprehensive understanding of evidence evaluation.

In addition, Giulia has a thorough understanding of a variety of economic evaluations, such as cost-effectiveness analysis, including cost-utility analysis. Similarly, she has gained experience in the collection of Patient- Reported Outcomes including the challenges involved in the face and content validity of their measures.

Ella is a senior market access analyst passionate about improving patient access to healthcare. Before joining Remap, she gained valuable experience at a leading pharmaceutical consulting firm, where she worked across a variety of therapy areas including rare diseases, oncology, and infectious diseases.

Her expertise includes compiling comprehensive evidence in global value dossiers, meticulously gathering and analysing data in primary research to provide actionable insights and conducting detailed literature reviews.

Beyond her professional achievements, Ella is a strong advocate for the benefits of nature for mental health, which she practices through hiking and wild swimming. Her commitment to well-being extends to her work, where she brings a holistic approach to her analytical and strategic thinking.

Ella holds a master’s degree in Biomedical Science from the University of Sheffield. Her academic background is distinguished by a focus on public awareness of science and novel laboratory technologies, areas she explored extensively during her final year.

Rahul is an accomplished professional with a diverse background in pharmacy and finance allowing him to approach business challenges with a holistic perspective, offering innovative solutions to clients in both sectors.

With a solid foundation as a qualified Pharmacist, Rahul possesses valuable clinical experience in primary care, enabling him to understand the intricacies of healthcare delivery from a practical perspective. As a passionate educator, Rahul invests his time towards researching new strategies that can help improve patient outcomes.

Rahul’s journey in the corporate world began at Deloitte working his way to assistant manager where he focused on leadership, project management and attention to detail. By leveraging these skills, Rahul is able to drive positive results for both clients and patients in the healthcare industry.

Rahul holds a Master’s Degree in Pharmacy from the University of Reading, where his dissertation looking at neurodegenerative disorders was awarded the Reading School of Pharmacy Award 2019.

Solen is an accomplished analyst with a robust foundation in data analysis and creative problem-solving. Her passion for translating knowledge into actionable results began during her PhD. She holds a master’s degree in nanotechnologies with distinction from the University Paris-Saclay and earned a PhD from the University of Manchester, specialising in virus biosensors.

Prior to joining Remap, Solen founded and led a company that brought together academics and business professionals, showcasing her strong communication skills and deep understanding of both sponsors’ and investors’ needs. Solen’s career reflects her dedication to bridging the gap between science and business, making her an invaluable asset in consultancy.

Joyce is an experienced analyst within the life sciences sector, specialising in intellectual property.

Holding a BSc in Biomedical Science with first-class honours from the University of Essex, she was recognised with the School of Life Sciences Excellence Scholarship. Continuing her academic journey, Joyce earned her master’s degree in biotechnology and business management from the University of Warwick.

Transitioning into the professional realm, Joyce joined a prominent global Intellectual Property firm as a Project Manager. Here, she collaborated closely with clients on various projects including research reports, webinars, and client workshops. This experience not only honed her skills in project management but also provided her with a deep understanding of research and analytics, as well as commercialisation strategies.

One notable project involved mapping the competitive landscape of a given indication, igniting Joyce’s interest in pricing and reimbursement strategies, particularly in the context of market access.

Beyond her professional endeavours, Joyce is passionate about exploring new health innovations and their potential impact on both healthcare systems and industry, seeking opportunities to contribute to transformative business practises.

Kacper recently graduated with a Master of Biology from the University of Oxford, where he developed a strong foundation in life sciences, research, and data analysis. During his time at Oxford, Kacper completed an MBiol research project at the prestigious Pandemic Sciences Institute, where he led independent research on HIV adaptation to the human immune system, contributing valuable insights towards future vaccine development. This experience honed his ability to manage complex data sets, conduct rigorous scientific analysis, and present findings clearly and effectively.

In addition to his academic achievements, Kacper has gained practical experience through internships at Jack Fertility, Evolvere Biosciences, and the Wellcome Centre for Human Genetics. These roles have equipped him to interpret complex scientific data, communicate effectively with scientific and non-scientific audiences, and contribute to developing innovative healthcare solutions. Kacper’s strong analytical abilities and research experience make him the perfect addition to the Remap Consulting team.

Nick is an analyst with a strong academic background in neuroscience and practical experience in pre-clinical research and market analysis. He brings expertise in data analysis, programming, and market research, making him a valuable asset to the team.

Nick recently graduated with a BSc (Hons) in Neuroscience from The University of Manchester, achieving high first-class honors. During his industrial placement at Storm Therapeutics Ltd, he gained hands-on experience in pre-clinical cancer research and led market research initiatives for new drug development, providing valuable insights into the pharmaceutical industry.

In addition to his scientific and analytical skills, Nick has demonstrated strong leadership abilities. At the Masood Entrepreneurship Centre, he successfully led a team to secure £50,000 in grant funding. His ability to interpret complex data, identify market opportunities, and contribute to strategic decision-making will support the team’s continued success.

Evie recently graduated with First-Class Honours in BSc Biomedical Sciences from the University of Manchester, giving her a strong scientific grounding and understanding of drug development processes. Her dissertation investigated the development of novel therapeutics targeting glutamatergic signalling pathways in treatment-resistant depression. Key findings from her science communication report contributed to her co-authoring an upcoming publication in the British Pharmacological Society’s journal.

In her final year at University, Evie received a first-place prize in the North-West Biotechnology Initiative Consulting Case Competition. This involved analysing clinical trial data and presenting strategic recommendations, requiring strong analytical abilities and effective communication of findings.

Alongside academics, Evie has gained a range of experience through various internships. As a Medical Writer, she researched and produced published articles discussing diverse therapeutic areas, developing skills in evidence synthesis and tailoring medical communications towards various audiences. During her summer placement as a Consultant Laboratory Technician, she supported analytical testing in product development processes, gaining insight into how scientific innovation aligns with commercial and regulatory expectations.

With over 23 years’ experience working within the pharmaceutical and healthcare consultancy industry, Sarah brings a wealth of experience in operational management, training development and design, and project support.

Using her extensive design techniques, allows Sarah to craft visually compelling presentations and interactive market access eLearning training programs. She consistently upholds the highest standards, ensuring that the content she produces aligns seamlessly with your company’s brand guidelines and technical specifications.

Employing a rich blend of instructional design techniques and methodologies, Sarah is adept at tailoring her approach to various learning environments. Her skill set covers a spectrum of delivery methods, ranging from virtual platforms to face-to-face interactions, including eLearning modules, classroom-based workshops, dynamic PowerPoint presentations, and engaging webinars.

Complementing her hands-on experience, Sarah holds an ISEB qualification in Program & Project Support Office, showcasing her commitment to maintaining the highest standards in project execution. Additionally, she proudly boasts an Articulate Storyline accreditation, underlining her expertise in creating effective training content.

Johnson brings a unique blend of entrepreneurial innovation and deep expertise in health economics and market access. As the founder of Otter Curiosity, he developed a social app powered by advanced AI technologies, including OpenAI, demonstrating his ability to integrate cutting-edge digital solutions into real-world applications.

With over five years of consultancy experience at Aquarius Population Health and PRMA Consulting, Chang-Shen has worked extensively in health economics and market access, providing strategic insights to optimize decision-making in the healthcare industry.

Holding a BSc in Pharmacy and an MSc in Health Economics and Decision Modelling, he combines a strong scientific foundation with expertise in AI adoption, data-driven decision-making, and digital transformation.

At Remap, Johnson will lead our Generative AI & Digital Adoption efforts, helping us drive innovation and maximize our digital capabilities in Market Access and Pricing. His expertise will be instrumental in shaping how AI enhances strategic planning, payer engagement, and evidence generation across the industry.

Andrea has over 20 years experience in graphic design, with a passion to create captivating and engaging presentations, branding materials, marketing collateral, and website design, for non-profits, corporations, and small businesses worldwide. She is also experienced in motion graphics, grant writing, video editing, social media communications, mural painting and project management.

Andrea likes to be creative and to think outside the box. She speaks Spanish, English, and Portuguese. Outside of work, Andrea enjoys spending time with her family, traveling, and is an avid movie fanatic! She’s also proud to support many NGOs.

Andrea holds a BA in Multimedia Animation from the Universidad San Francisco de Quito in Ecuador, as well as a Master’s degree in Project Management from the Universidad para la Cooperación Internacional in Mexico.

Bea brings over a decade of experience in the events industry, where her strong organisational skills and keen eye for detail have proven invaluable. As an Operations Executive, Bea is adept at coordinating logistics, managing schedules, and ensuring seamless event execution. Her ability to multitask and problem-solve under pressure makes her a valuable asset to her team.

Born in Menorca, Bea is fluent in Spanish, Catalan, and English, adding a multicultural edge to her professional capabilities. She leverages her linguistic skills to communicate effectively with diverse stakeholders, ensuring clarity and efficiency in all interactions.

Outside of work, Bea enjoys baking and even runs her own cake business! She loves spending time outdoors and traveling back home to Menorca whenever she can to enjoy the sunshine. Bea’s varied interests and background bring a unique perspective to her role.

Bea holds a Bachelor’s degree in Journalism Media and Cultural Studies from Cardiff University

Petroc is responsible for translating emerging AI capabilities into reliable tools and services that support our pricing and market access work. He focuses on building scalable, user-centred products and integrations that make generative AI practical, safe and effective for day-to-day use.

Before joining Remap, Petroc held senior and lead development roles across market access, education technology and industrial software. He has led the development and rollout of an enterprise multi-LLM AI platform, introduced document-extraction features and established security, compliance and performance practices for production environments. He has also directed teams delivering multi-tenant SaaS platforms, process transformations and large-scale data migrations.

His technical background spans full-stack engineering with .NET and C#, cloud development on Microsoft Azure, modern web frameworks, API design, CI/CD and automated testing.

A fluent Welsh speaker, he enjoys travelling and experimenting with home server and automation projects.

Lyubo is a Business Development Director with extensive experience in strategic sales, client engagement, and commercial growth across the pharmaceutical, biotech, and life sciences sectors. He has worked with leading global organisations to build strong pipelines, drive market expansion, and deliver tailored solutions to complex client needs.

Most recently, Lyubo held several senior business development roles at Cytel, where he was responsible for generating new business across EMEA, leading cross-functional sales strategies, and expanding into white space territories. His success in initiating CxO-level partnerships and exceeding sales targets was recognised with Cytel’s prestigious President’s Club award in 2023. He also played a key role in mentoring interns and advancing DEI initiatives, including organising global LGBTQ+ events.

Lyubo’s experience also includes commercial roles at STARLAB International and Appleton Woods, where he led go-to-market strategies, secured multimillion-pound portfolios, and launched impactful digital and sustainability initiatives.

Lyubo holds a First-Class Honours BSc in Business and Management from Aston University and has completed executive education in Leadership, Strategy, and Innovation at Edinburgh Napier University.

Jessica Riggs Ivy is a business development professional with a strong track record of driving client engagement and strategic growth within the healthcare consulting and pharmaceutical industries. As the US Director of Business Development at Remap Consulting, she is working to expand Remap’s business into the US; working with US based pharmaceutical and biotech companies to support their pricing, market access, and reimbursement strategies in the EU and UK.

With a background in strategy consulting, international diplomacy, and health science, Jessica is well positioned to understand the market access and strategy needs of biotech and biopharma. Before joining Remap Consulting, Jessica held leadership and strategy positions at the US CDC, USASID, ZS Associates, and in emerging Pharmatech. She speaks several languages and has lived in 8 countries. She also served as a US Peace Corps Volunteer.

Jessica holds a Bachelor of Arts in Economics from UCLA, and a Master of Public Health with concentrations in Epidemiology and Health Policy from Boston University.

Outside of work Jessica is passionate about travel, social issues, yoga, the outdoors and wildlife, hiking, music, art, and weightlifting. She is also a dedicated mum.